OEM/ODM Manufacturer invasive candidiasis - Carbapenem-resistant K.N.I. Detection K-Set (Lateral Flow Assay) – Genobio

Product Introduction

The Carbapenem-resistant K.N.I. Detection K-Set (Lateral Flow Assay) is an immunochromatographic test system intended for the qualitative detection of KPC-type, NDM-type, IMP-type carbapenemase in bacterial colonies. The assay is a prescription-use laboratory assay which can aid in the diagnosis of KPC-type, NDM-type, IMP-type carbapenem resistant strains.

Carbapenems are often the last resort for treating multidrug-resistant gram-negative organisms, particularly those that produce AmpC and extended-spectrum beta-lactamases, which destroy most beta-lactams except for carbapenems.

Characteristics

Advantage

• Rapid
  Obtain result within 15 min, 3 days earlier than traditional detection methods
• Simple
  Easy to use, minimum manual operation, detailed instructions
• Comprehensive & flexible
  Combines KPC, NDM, IMP tests together, gives a comprehensive detection of the gene types of carbapenem-resistant bacteria infected.
• Intuitive result
  Visual reading result, clear test lines reduce misreading of results
• Economic
  2-30℃ storage and transportation, cost-effective and convenient

What are CRE and antibiotic resistance?

Carbapenem-resistant Enterobacteriaceae (CRE) are strains of bacteria that are resistant to an antibiotic class (carpabenem) used to treat severe infections. CRE are also resistant to most other commonly used antibiotics and in some cases to all available antibiotics.

• Antibiotic resistance is one of the biggest threats to global health, food security, and development today.
• Antibiotic resistance can affect anyone, of any age, in any country.
• Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process.
• A growing number of infections – such as pneumonia, tuberculosis, gonorrhoea, and salmonellosis – are becoming harder to treat as the antibiotics used to treat them become less effective.
• Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality

Operation

Order Information